Dissertation > Excellent graduate degree dissertation topics show
Case analysis of different gender systemic scleroderma
Author: WangLiNa
Tutor: ZhengMin
School: Zhejiang University
Course: Systemic scleroderma
Keywords: Systemic scleroderma
CLC: R593.25
Type: Master's thesis
Year: 2011
Downloads: 41
Quote: 0
Read: Download Dissertation
Abstract
|
Objective To investigate gender systemic scleroderma (systemic sclerosis, SSc) patients in the clinical manifestations and laboratory findings aspects of similarities and differences . Methods A retrospective analysis of 52 cases of hospitalized patients with SSc clinical manifestations, laboratory data , in 19 male patients and 33 female patients were compared. Results Men proportion of patients with diffuse SSc ( 73.68% ) was significantly higher than female SSc patients (30.30%) (P lt; 0.01). Male patients with SSc sausage-like means a change in rate ( 36.84% ) than female SSc patients (66.67%) (P lt; 0.05). Male SSc patients with urinary protein positive rate ( 50.00% ) , lactate dehydrogenase (LDH) increased rate ( 50.00% ) were higher than female patients with SSc positive rate of urinary protein (22.58%), LDH increased rate ( 21.21% ) ( P lt; 0.05). Male SSc patients with rheumatoid factor (RF) positive rate was 0 , antinuclear antibody (ANA) positive rate ( 57.89% ) , anti-ENA antibodies (ENA) positive rate ( 43.75% ) were lower than in female patients with SSc RF positive rate ( 28.00%), ANA -positive rate (87.10%), ENA positive rate ( 74.19% ) . Conclusion male patients with diffuse SSc high proportion of women is about 2 times . Meanwhile, men are more vulnerable SSc patients with impaired renal function , should be vigilant. But ANA, ENA these immunological indicators positive rate is low, is not conducive to the early detection of disease.
|
Related Dissertations
- The Association Analysis of HLA-DRB1 Allele and Systemic Scleroderma in Guangxi,R593.25
- The Effects of Chinese Traditional Herbs and Constituents of Them on Proliferation and Type Ⅰ/Ⅲ Procollagen Expression of Systemic Sclerosis Fibroblasts,R259.9
- Expression of CD40LG in CD4~+T、CD8~+T Cells from Patients with Scleroderma,R593.25
- Relationship between Prolactin/Prolactin Receptor Pathway and CD154 Expression and Its Influence on Th1/Th2 Cytokine Balance,R392
- Effects of 9-cis-retinoic Acid on the mRNA Expression of Type Ⅰ Collagen and HGF/c-Met in Skin Fibroblasts of Patients with Systemic Sclerosis,R593.25
- Its mechanism of hepatocyte growth factor (HGF) systemic scleroderma skin fibroblasts of type I collagen,R593.25
- Exploration the Association of HLA-DRB1 Alleles with Systemic Sclerosis in Guangxi Zhuang and Han Nationality Patients,R593.25
- The Association of HLA-DQA1, DQB1 Alleles with Systemic Sclerosis of the Zhuang and Han Nationality in Guangxi,R593.25
- Clinical Analysis of 71 Cases of Systemic Scleroderma,R593.1
- Expression of CD40LG in CD4~+T、CD8~+T Cells from Patients with Scleroderma,R593.25
- The Association of HLA-DQA1, DQB1 Alleles with Systemic Sclerosis of the Zhuang and Han Nationality in Guangxi,R593.25
- Exploration the Association of HLA-DRB1 Alleles with Systemic Sclerosis in Guangxi Zhuang and Han Nationality Patients,R593.25
- Its mechanism of hepatocyte growth factor (HGF) systemic scleroderma skin fibroblasts of type I collagen,R593.25
- Effects of 9-cis-retinoic Acid on the mRNA Expression of Type Ⅰ Collagen and HGF/c-Met in Skin Fibroblasts of Patients with Systemic Sclerosis,R593.25
- The Association Analysis of HLA-DRB1 Allele and Systemic Scleroderma in Guangxi,R593.25
- Study on the Expression and Significance of MMP-9, TIMP-1 in Systemic Scleroderma,R593.25
- Analysis of Gene Mutations in Two Chinese Patients with Tuberous Sclerosis Complex,R593.25
- The Diagnose of Scleroderma by Use of Multiphoton Laser Scanning Microscopy,R593.25
- The Roles of MMP-9 and TIMP-1 during the Progression of Skin Sclerosis in Mouse Model and Effects of Simvastatin on the Sclerotic Skin in Mouse Model,R593.25
- The MicroRNA Role Research on the Systemic Scleroderma Pathogenesis,R593.25
CLC: > Medicine, health > Internal Medicine > Systemic disease > Autoimmune diseases > Autoimmune diseases, connective tissue disease > Scleroderma
© 2012 www.DissertationTopic.Net Mobile
|